Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
20 results
D1.428 - Fungal Microbiome Diversity in Urban Forest Decreases Asthma and Allergic Inflammation
D1.431 - Associations of the composition of intestinal microbiota with the initial manifestations of IgE-mediated food allergy in children 6-12 months old
D1.433 - The effect of preventive administration of probiotic strain E. coli 083:H24:K31 on selected immune characteristics of eight-year-old children
D2.415 - Application of magnetic particle chemiluminescence technology to detect sensitization in patients in Guangzhou, China: a study base on real-world medical data
D2.419 - Quality of life and measures of well-being of Canadian patients with HAE C1-INH based on data from the 2020 and 2024 national surveys
D2.420 - Sensitization Profile of Lipocalins: sIgE Analysis in a Large Cohort of Patients with Suspected Allergies
D2.413 - Association of sensitization to fur animal allergens and Bet v 1 in the Russian population
D2.414 - Trends in the prevalence of asthma in Korean children: a population-based study from 1995 to 2022
D2.416 - Online Education Significantly Improves Physicians’ Knowledge of Novel Long-Term Prophylaxis Therapies for Hereditary Angioedema
D2.417 - Research transparency, reproducibility and accessibility in Allergy, 2003 – 2023: Preliminary results of the TRACES study
D2.418 - Risk Factors for Severe Allergic Rhinitis and the Association with Serum sIgE Levels: A Study in Guangzhou, China
D3.364 - Effect of Omalizumab on Inflammatory and Immune Biomarkers in Mast Cell-Mediated Angioedema
D3.358 - The impact of limited access to On-Demand Treatment for Hereditary Angioedema on Quality of life: a comparison between two income settings
D3.359 - Study of olfaction in patients with chronic rhinosinusitis with nasal polyposis undergoing Mepolizumab treatment
D3.362 - Use and safety of canakinumab during pregnancy
D3.363 - Vitamin D3 deficiency promotes epithelial-to-mesenchymal transition and thus favours pulmonary fibrosis development in the murine model of hypersensitivity pneumonitis
D3.365 - The role of anosmia in predicting biologic responsiveness for Chronic Rhinosinusitis with Nasal Polyposis
D3.366 - Exploring potential predictive factors for time to response to Omalizumab treatment in a Romanian subset of patients with Chronic Spontaneous Urticaria
D3.367 - Mental health, sexual functionality, quality of life, and patient experiences with chronic rhinosinusitis with nasal polyps at UNIMEQ-ORL in Bogotá, Colombia, 2022-2024: a mixed-methods study
D3.368 - Analysis of discontinuation of omalizumab in patients with chronic spontaneous and/or inducible urticaria in a tertiary hospital in one year
Download the app
The congress at your fingertips
Available on
Download